Ledger.Open graph →
SEC Form D · filed December 27, 2013

NexImmune, Inc

Offering
$2.0M
Sold
$250K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
GAITHERSBURG, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Keyur Sathe · Dallas, TXDirectorAmanda S. Jean-Baptiste · London, United KingdomExec · DirectorDavid, Jr. D. Peete · Arlington, VAExec · DirectorSlain Cappeluti · Gaithersburg, MDExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗